Cargando…
Reporter Replicons for Antiviral Drug Discovery against Positive Single-Stranded RNA Viruses
Single-stranded positive RNA ((+) ssRNA) viruses include several important human pathogens. Some members are responsible for large outbreaks, such as Zika virus, West Nile virus, SARS-CoV, and SARS-CoV-2, while others are endemic, causing an enormous global health burden. Since vaccines or specific...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354593/ https://www.ncbi.nlm.nih.gov/pubmed/32486283 http://dx.doi.org/10.3390/v12060598 |
_version_ | 1783558120897773568 |
---|---|
author | Fernandes, Rafaela S. Freire, Marjorie C. L. C. Bueno, Renata V. Godoy, Andre S. Gil, Laura H. V. G. Oliva, Glaucius |
author_facet | Fernandes, Rafaela S. Freire, Marjorie C. L. C. Bueno, Renata V. Godoy, Andre S. Gil, Laura H. V. G. Oliva, Glaucius |
author_sort | Fernandes, Rafaela S. |
collection | PubMed |
description | Single-stranded positive RNA ((+) ssRNA) viruses include several important human pathogens. Some members are responsible for large outbreaks, such as Zika virus, West Nile virus, SARS-CoV, and SARS-CoV-2, while others are endemic, causing an enormous global health burden. Since vaccines or specific treatments are not available for most viral infections, the discovery of direct-acting antivirals (DAA) is an urgent need. Still, the low-throughput nature of and biosafety concerns related to traditional antiviral assays hinders the discovery of new inhibitors. With the advances of reverse genetics, reporter replicon systems have become an alternative tool for the screening of DAAs. Herein, we review decades of the use of (+) ssRNA viruses replicon systems for the discovery of antiviral agents. We summarize different strategies used to develop those systems, as well as highlight some of the most promising inhibitors identified by the method. Despite the genetic alterations introduced, reporter replicons have been shown to be reliable systems for screening and identification of viral replication inhibitors and, therefore, an important tool for the discovery of new DAAs. |
format | Online Article Text |
id | pubmed-7354593 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73545932020-07-23 Reporter Replicons for Antiviral Drug Discovery against Positive Single-Stranded RNA Viruses Fernandes, Rafaela S. Freire, Marjorie C. L. C. Bueno, Renata V. Godoy, Andre S. Gil, Laura H. V. G. Oliva, Glaucius Viruses Review Single-stranded positive RNA ((+) ssRNA) viruses include several important human pathogens. Some members are responsible for large outbreaks, such as Zika virus, West Nile virus, SARS-CoV, and SARS-CoV-2, while others are endemic, causing an enormous global health burden. Since vaccines or specific treatments are not available for most viral infections, the discovery of direct-acting antivirals (DAA) is an urgent need. Still, the low-throughput nature of and biosafety concerns related to traditional antiviral assays hinders the discovery of new inhibitors. With the advances of reverse genetics, reporter replicon systems have become an alternative tool for the screening of DAAs. Herein, we review decades of the use of (+) ssRNA viruses replicon systems for the discovery of antiviral agents. We summarize different strategies used to develop those systems, as well as highlight some of the most promising inhibitors identified by the method. Despite the genetic alterations introduced, reporter replicons have been shown to be reliable systems for screening and identification of viral replication inhibitors and, therefore, an important tool for the discovery of new DAAs. MDPI 2020-05-30 /pmc/articles/PMC7354593/ /pubmed/32486283 http://dx.doi.org/10.3390/v12060598 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Fernandes, Rafaela S. Freire, Marjorie C. L. C. Bueno, Renata V. Godoy, Andre S. Gil, Laura H. V. G. Oliva, Glaucius Reporter Replicons for Antiviral Drug Discovery against Positive Single-Stranded RNA Viruses |
title | Reporter Replicons for Antiviral Drug Discovery against Positive Single-Stranded RNA Viruses |
title_full | Reporter Replicons for Antiviral Drug Discovery against Positive Single-Stranded RNA Viruses |
title_fullStr | Reporter Replicons for Antiviral Drug Discovery against Positive Single-Stranded RNA Viruses |
title_full_unstemmed | Reporter Replicons for Antiviral Drug Discovery against Positive Single-Stranded RNA Viruses |
title_short | Reporter Replicons for Antiviral Drug Discovery against Positive Single-Stranded RNA Viruses |
title_sort | reporter replicons for antiviral drug discovery against positive single-stranded rna viruses |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354593/ https://www.ncbi.nlm.nih.gov/pubmed/32486283 http://dx.doi.org/10.3390/v12060598 |
work_keys_str_mv | AT fernandesrafaelas reporterrepliconsforantiviraldrugdiscoveryagainstpositivesinglestrandedrnaviruses AT freiremarjorieclc reporterrepliconsforantiviraldrugdiscoveryagainstpositivesinglestrandedrnaviruses AT buenorenatav reporterrepliconsforantiviraldrugdiscoveryagainstpositivesinglestrandedrnaviruses AT godoyandres reporterrepliconsforantiviraldrugdiscoveryagainstpositivesinglestrandedrnaviruses AT gillaurahvg reporterrepliconsforantiviraldrugdiscoveryagainstpositivesinglestrandedrnaviruses AT olivaglaucius reporterrepliconsforantiviraldrugdiscoveryagainstpositivesinglestrandedrnaviruses |